|
TMTC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12809999996966E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.480000E-03 |
| Normal-vs-Stage2 |
4.300400E-03 |
| Normal-vs-Stage3 |
1.0013000000253E-06 |
| Normal-vs-Stage4 |
1.31769994915487E-09 |
| Stage1-vs-Stage2 |
3.156600E-01 |
| Stage1-vs-Stage3 |
2.257800E-03 |
| Stage1-vs-Stage4 |
3.02510000382838E-08 |
| Stage2-vs-Stage3 |
2.528800E-01 |
| Stage2-vs-Stage4 |
7.144600E-03 |
| Stage3-vs-Stage4 |
3.501800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34600000001317E-06 |
| Normal-vs-AfricanAmerican |
4.392000E-04 |
| Normal-vs-Asian |
8.682200E-01 |
| Caucasian-vs-AfricanAmerican |
5.451000E-01 |
| Caucasian-vs-Asian |
1.301150E-01 |
| AfricanAmerican-vs-Asian |
1.236830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.64279999948347E-07 |
| Normal-vs-Female |
1.687910E-02 |
| Male-vs-Female |
5.8208000000004E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.061100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.09820000000027E-05 |
| Normal-vs-Age(61-80Yrs) |
2.18549999999595E-05 |
| Normal-vs-Age(81-100Yrs) |
9.462000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.992200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.621800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.221400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.998400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.223000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.810200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.864400E-01 |
| Normal-vs-Grade 2 |
1.032310E-02 |
| Normal-vs-Grade 3 |
2.2591000004013E-07 |
| Normal-vs-Grade 4 |
1.0683998130645E-10 |
| Grade 1-vs-Grade 2 |
2.548600E-01 |
| Grade 1-vs-Grade 3 |
1.225770E-02 |
| Grade 1-vs-Grade 4 |
1.95516000000007E-05 |
| Grade 2-vs-Grade 3 |
4.020400E-04 |
| Grade 2-vs-Grade 4 |
1.7907997307276E-10 |
| Grade 3-vs-Grade 4 |
3.177000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.275800E-01 |
| Normal-vs-ccB subtype |
1.61200000015072E-08 |
| ccA subtype-vs-ccB subtype |
9.81129621990817E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.83350000000049E-05 |
| Normal-vs-N1 |
7.118200E-03 |
| N0-vs-N1 |
3.077800E-01 |
|
|
